JoVE Logo

Zaloguj się

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

58.8K Views

08:40 min

March 1st, 2019

DOI :

10.3791/59010-v

March 1st, 2019


Przeglądaj więcej filmów

Pseudotyped Particles

Rozdziały w tym wideo

0:04

Title

0:41

Cell Seeding for Pseudotyped Particle Production

2:05

Three-plasmid Co-transfection

3:53

Pseudotyped Particles Collection

4:46

Pseudotyped Particle Infection

5:54

Infectivity Quantification by Luciferase Assay Readout

7:04

Results: Infectivity Assays of SARS-CoV S and MERS-CoV S Pseudotyped Particles

8:02

Conclusion

Powiązane Filmy

article

11:08

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

35.1K Views

article

07:42

An In vitro Model to Study Heterogeneity of Human Macrophage Differentiation and Polarization

18.6K Views

article

06:48

Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice

12.3K Views

article

10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

36.1K Views

article

08:10

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

8.2K Views

article

10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

4.2K Views

article

07:15

Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity

2.1K Views

article

05:49

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay

1.5K Views

article

06:17

Expression and Purification of Virus-like Particles for Vaccination

21.8K Views

article

03:53

Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV

1.0K Views

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone